MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Identification and characterization of anti-prionic compounds that disassemble αSyn prions as a novel therapeutic approach for synucleinopathies

    D. Willbold, M. Sevenich, W. Hoyer, J. Mohrlüder, A. Willuweit (Jülich, Germany)

    Objective: Stabilization of monomeric α-synuclein protein (αSyn) by transient and high-affinity binding ligands is a novel and highly innovative anti-prionic treatment strategy for synucleinopathies .…
  • MDS Virtual Congress 2020

    Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy

    Y. Saitoh, M. Miyazaki, A. Tsuru, Y. Takahashi (Kodaira, Tokyo, Japan)

    Objective: To investigate whether REM sleep without atonia (RWA) is associated with sleep architecture in patients with multiple system atrophy (MSA). Background: In MSA patients,…
  • MDS Virtual Congress 2020

    Correlations between amantadine usage, gait, and cognition in PSP: a post hoc analysis of the davunetide trial

    M. Dale, B. Brumbach, A. Hiller (Portland, OR, USA)

    Objective: Amantadine anecdotally improves gait and balance in PSP, potentially by increasing alertness, but there are no definitive data to support this observation. We investigated…
  • MDS Virtual Congress 2020

    Temporhythmal Correction: The New Way of Therapy and Diagnostic Secondary Vascular Parkinsonism

    D.T Akramova (Tashkent, Uzbekistan)

    Objective: It is known that, in vascular parkinsonism (VP) and Parkinson’s disease (PD) it is observed shortening of steps, bradikinesia, oligokinesia, gait disorders and also…
  • MDS Virtual Congress 2020

    May Safinamide have a Role in Atypical Parkinsonism? A Retrospective Study in Clinical Practice

    F. Rodríguez Jorge, A. Beltrán Corbellini, J.L Chico García, P. Parra Díaz, P. Pérez Torre, B. Baena Álvarez, I. Parées Moreno, J.L López-Sendón, J.C Martínez Castrillo, A. Alonso Cánovas, S. Fanjul Arbós (Madrid, Spain)

    Objective: To evaluate efficacy and safety of safinamide in atypical parkinsonian syndromes. Background: Safinamide (50-100 mg) has proved efficacy as an add-on treatment to levodopa…
  • MDS Virtual Congress 2020

    Mutations of COX20 affect the assembly and function of complex IV causing early onset ataxia, dystonia and neuropathy

    Y.M Liu, P.Z Li, DD. Guo, H.B LV, Y.L Zhang (Jinan, China)

    Objective: To find the causes of an early onset complex movement disorder in two sisters from a non-consanguineous family, and confirm the COX20 variants responsible for such mitochondrial…
  • MDS Virtual Congress 2020

    Clinical progression of Parkinson’s disease: insights from the NINDS common data elements

    M. Lewis, E. Harkins, E. Lee, C. Stetter, B. Snyder, T. Corson, G. Du, L. Kong, X. Huang (Hershey, PA, USA)

    Objective: To synchronize data collection, the National Institute of Neurological Disorders and Stroke recommended Common Data Elements (CDEs) for use in Parkinson’s disease (PD) research.…
  • MDS Virtual Congress 2020

    Home validation of a smartphone-based tapping task to assess medication responsiveness in Parkinson’s disease

    S. Broeder, R. Bussels, S. Vanden Schoor, G. Roussos, J-J. Orban deXivry, A. Nieuwboer (Leuven, Belgium)

    Objective: To validate a timed tapping task (TTT) on a smartphone to ascertain differences in OFF- and ON-phases in Parkinson’s disease (PD) in the home…
  • MDS Virtual Congress 2020

    The impact of motor and non-motor symptoms on walking capacity in people with Parkinson’ disease

    H. Khalil, R. Rayhan, A. Al-Sharman, A. Aburub, K. El-Salem (Irbid, Jordan)

    Objective: This study aimed to evaluate the motor and non-motor factors associated with walking capacity in people with Parkinson’s disease (PwPD). Background: Walking over short…
  • MDS Virtual Congress 2020

    Do improvements to primary symptoms from sensory training differ in Parkinson’s disease ON vs. OFF dopaminergic medications?

    K. Sangarapillai, B. Norman, E. Beck, Q. Almeida (Waterloo, ON, Canada)

    Objective: Investigate whether the effects of sensory training differ ON vs. OFF medication in Parkinson’s disease using the Unified Parkinson’s Disease Rating Scale (UPDRS-III). Background:…
  • « Previous Page
  • 1
  • …
  • 134
  • 135
  • 136
  • 137
  • 138
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley